Back
Fomento Economico Mexicano SAB de CV Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Sell
48
FMX
Fomento Economico Mexicano SAB de CV
Last Price:
97.70
Seasonality Move:
7.51%
Buy
82
MDGL
Madrigal Pharmaceuticals
Last Price:
331.02
Seasonality Move:
31.67%
Sell
48
Fomento Economico Mexicano SAB de CV (FMX)
is a Sell
Is Fomento Economico Mexicano SAB de CV a Buy, Sell or Hold?
- The current Fomento Economico Mexicano SAB de CV [FMX] share price is $96.74. The Score for FMX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- FMX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
82
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $319.58. The Score for MDGL is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
FMX Stock Price Chart
What is Fomento Economico Mexicano SAB de CV's stock price today?
-
The Fomento Economico Mexicano SAB de CV share price today is $96.74
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FMX is experiencing slight selling pressure.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $319.58
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
FMX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.16 | Sell |
| Relative Strength Index (14 RSI): | 41.97 | Sell |
| Chaikin Money Flow: | -227477 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (97.11 - 99.11) | Sell |
| Bollinger Bands (100): | (99.48 - 111.58) | Sell |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.37 | Buy |
| Relative Strength Index (14 RSI): | 85.5 | Buy |
| Chaikin Money Flow: | 2945933 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (194.64 - 241.02) | Buy |
| Bollinger Bands (100): | (221.59 - 279.03) | Buy |
FMX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 96.98 | Sell |
| 20-day SMA: | 97.9 | Sell |
| 50-day SMA: | 100.42 | Sell |
| 200-day SMA: | 115.38 | Sell |
| 8-day EMA: | 97.05 | Sell |
| 20-day EMA: | 97.95 | Sell |
| 50-day EMA: | 100.82 | Sell |
| 200-day EMA: | 109.53 | Sell |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 230.72 | Buy |
| 20-day SMA: | 219.8 | Buy |
| 50-day SMA: | 228.31 | Buy |
| 200-day SMA: | 241.11 | Buy |
| 8-day EMA: | 244.62 | Buy |
| 20-day EMA: | 228.06 | Buy |
| 50-day EMA: | 230.04 | Buy |
| 200-day EMA: | 234.49 | Buy |
Fomento Economico Mexicano SAB de CV Earnings Growth & FMX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and an increase next year of $0.00 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $4.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.19 per share, and an increase next year of $9.06 per share.
Fomento Economico Mexicano SAB de CV Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||